1. Home
  2. EVOK vs AYRO Comparison

EVOK vs AYRO Comparison

Compare EVOK & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • AYRO
  • Stock Information
  • Founded
  • EVOK 2007
  • AYRO 2017
  • Country
  • EVOK United States
  • AYRO United States
  • Employees
  • EVOK N/A
  • AYRO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • AYRO Telecommunications Equipment
  • Sector
  • EVOK Health Care
  • AYRO Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • AYRO Nasdaq
  • Market Cap
  • EVOK 4.2M
  • AYRO 4.3M
  • IPO Year
  • EVOK 2013
  • AYRO N/A
  • Fundamental
  • Price
  • EVOK $2.95
  • AYRO $0.42
  • Analyst Decision
  • EVOK
  • AYRO
  • Analyst Count
  • EVOK 0
  • AYRO 0
  • Target Price
  • EVOK N/A
  • AYRO N/A
  • AVG Volume (30 Days)
  • EVOK 14.3K
  • AYRO 340.4K
  • Earning Date
  • EVOK 05-13-2025
  • AYRO 05-14-2025
  • Dividend Yield
  • EVOK N/A
  • AYRO N/A
  • EPS Growth
  • EVOK N/A
  • AYRO N/A
  • EPS
  • EVOK N/A
  • AYRO N/A
  • Revenue
  • EVOK $11,594,083.00
  • AYRO $5,426.00
  • Revenue This Year
  • EVOK $57.82
  • AYRO N/A
  • Revenue Next Year
  • EVOK $59.12
  • AYRO N/A
  • P/E Ratio
  • EVOK N/A
  • AYRO N/A
  • Revenue Growth
  • EVOK 89.89
  • AYRO N/A
  • 52 Week Low
  • EVOK $1.94
  • AYRO $0.34
  • 52 Week High
  • EVOK $12.32
  • AYRO $0.96
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 38.86
  • AYRO 44.44
  • Support Level
  • EVOK $3.33
  • AYRO $0.37
  • Resistance Level
  • EVOK $3.66
  • AYRO $0.43
  • Average True Range (ATR)
  • EVOK 0.29
  • AYRO 0.04
  • MACD
  • EVOK -0.06
  • AYRO 0.01
  • Stochastic Oscillator
  • EVOK 2.99
  • AYRO 55.67

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About AYRO AYRO Inc.

AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: